Contracts
EPIC Care Link & Monitor Computer System Access Agreement (MCSA) Per Sponsor
Please note that if the name is not on the list, the contract has not been executed at this time.
| Sponsor Name | Epic Care Link Agreement | MCSA |
| Abbott Point of Care, Inc. | √ | |
| AbbVie, Inc. | √ | √ |
| Acerta Pharma, B.V. | √ | |
| Accular Biotechnology Inc. | √ | |
| Actuate Therapeutics, Inc. | √ | √ |
| Advenchen Laboratories, LLC | √ | |
| Aeglea BioTherapeutics, Inc. | √ | |
| Agenus, Inc. | √ | |
| Agios Pharmaceuticals, Inc. | √ | |
| Alavant Sciences, Inc. | √ | |
| Alexion Pharmaceuticals, Inc. | √ | |
| Alira Health Boston, LLC | √ | √ |
| Alkermes, Inc. | √ | |
| Alliance for Clinical Trials in Oncology | √ | |
| AlloVir, Inc. | √ | |
| ALung Technologies, Inc. | √ | |
| ALX Oncology, Inc. | √ | |
| Alpha Oncology, Inc. | √ | |
| Ambu, Inc. | √ | |
| American Oncologic Hospital d/b/a Hospital of the Fox Chase Cancer Center | √ | |
| Amgen, Inc. | √ | √ |
| Amplyx Pharmaceuticals, Inc. | √ | |
| AngioDynamics, Inc. | √ | √ |
| Applied Therapeutics, Inc. | √ | |
| Aptevo Therapeutics, Inc. | √ | |
| Aravive, Inc. | √ | |
| Arcus Biosciences, Inc. | √ | |
| Armata Pharmaceuticals, Inc. | √ | |
| ASRC Federal Data Networx, LLC | √ | |
| Astellas Pharma Global Development, Inc. | √ | |
| Astex Pharmaceuticals, Inc. | √ | |
| AstraZeneca Pharmaceuticals, LP | √ | |
| AVEO Pharmaceuticals | √ | |
| Basilea Pharmaceuticals | √ | |
| Beat AML, LLC | √ | |
| Beaufort, LLC | √ | |
| BeiGene USA, Inc. | √ | |
| Bellicum Pharmaceuticals, Inc. | √ | |
| BerGenBio ASA | √ | |
| Biocept, Inc. | √ | √ |
| BioMarin Pharmaceutical, Inc. | √ | √ |
| Biorasi | √ | √ |
| Black Diamond Therapeutics, Inc. | √ | |
| BlackSwan Vascular, Inc. | √ | |
| Blueprint Medicines Corp. | √ | |
| Boston Scientific Corporation | √ | |
| BRAINBox Solutions, Inc. | √ | |
| Bristol-Myers Squibb Company | √ | |
| Caelum Biosciences | √ | |
| CanFite Biopharma, Ltd. | √ | √ |
| CareDX, Inc. | √ | |
| Caris MPI, Inc. | √ | |
| CARsgen Therapeutics Corporation | √ | |
| Castle Biosciences | √ | |
| Catalyst Clinical Research, LLC (for EISAI study only) | √ | √ |
| Cato Research, LLC | √ | |
| Cedars-Sinai Medical Center | √ | |
| Celgene Corporation | √ | |
| Cellectar Biosciences, Inc. | √ | |
| Cerus Corporation | √ | |
| Clinipace (on behalf of Surface Oncology) | √ | |
| Clinlogix | √ | |
| Clovis Oncology, Inc. | √ | |
| Comprehensive Research Associates, LLC | √ | |
| Cook Research Inc. | √ | |
| Corcept Therapeutics, Inc. | √ | |
| Cornell | √ | √ |
| Courante Oncology | √ | √ |
| CRISPR Therapeutics, Inc. | √ | |
| Criterium, Inc. | √ | |
| CSA Medical, Inc. | √ | |
| CTI Clinical Trial Services, Inc. | √ | √ |
| CTI Clinical Trial Services, Inc. on behalf of Angion Therapeutics | √ | |
| CTI - Renovion | √ | |
| Cullinan Oncology, Inc. | √ | √ |
| CymaBay Therapeutics, Inc. | √ | |
| Daiichi Sankyo, Inc. | √ | |
| Dana-Farber Cancer Institute, Inc. | √ | |
| Delta-Fly Pharma, Inc. | √ | |
| Denovo Biopharma, LLC | √ | |
| Duke Clinical Research Institute (Duke University) | √ | |
| ECOG-ACRIN Medical Research Foundation | √ | √ |
| Endocyte, Inc. | √ | |
| Edwards Lifesciences, LLC | √ | |
| Elicio Therapeutics, Inc. | √ | |
| enGene, Inc. | √ | |
| Ergomed Clinical Research, Inc. | √ | √ |
| Exelixis, Inc. | √ | √ |
| Fate Therapeutics, Inc. | √ | |
| Forma Therapeutics, Inc. | √ | |
| Formation Biologics Corporation | √ | |
| Fortrea, Inc. | √ | |
| Fox Chase Cancer Center | √ | |
| G1 Therapeutics, Inc. | √ | |
| Galera Therapeutics | √ | |
| Genentech, Inc. | √ | |
| Genmab US, Inc. | √ | √ |
| Geron Corporation | √ | |
| GlaxoSmithKline, LLC | √ | |
| Global Coalition for Adaptive Research | √ | |
| GT Medical Technologies | √ | |
| Guardant Health, Inc. | √ | √ |
| Haihe Biopharma Co., Ltd. | √ | |
| Harpoon Therapeutics | √ | |
| Hart Clinical Consultants on behalf of Route 92 Medical, Inc. | √ | |
| Hemostasis, LLC | √ | |
| Hookipa Pharma, Inc. | √ | |
| Hoosier Cancer Research Network, Inc. | √ | |
| ICON Clinical Research, LLC | √ | √ |
| ICON Clinical Research Limited on behalf of Gilead Sciences, Inc. | √ | |
| ICON on behalf of Regulus Therapeutics | √ | |
| IMARC Research, Inc. | √ | |
| Immune-Onc Therapeutics, Inc. | √ | |
| Inari Medical, Inc. | √ | |
| Incyte Corporation | √ | |
| Inhibrx, Inc. | √ | |
| Indiana University | √ | √ |
| Inflammatix, Inc. | √ | |
| Institute for Clinical Research, Inc. (with PPD as CRO) | √ | |
| Integra LifeSciences Corporation | √ | |
| Ionis Pharmaceuticals, Inc. | √ | |
| Inovio Pharmaceuticals | √ | |
| IQVIA | √ | √ |
| IQVIA RDS, Inc. | √ | |
| INSIGHT Washington International Coordinating Center | √ | |
| Iterion Therapeutics | √ | √ |
| Janssen Research and Development, LLC | √ | |
| Johns Hopkins University | √ | |
| K6 Therapeutics, Inc. | √ | |
| K36 Therapeutics, Inc. | √ | |
| Karyopharm Therapeutics, Inc. | √ | √ |
| Kura Oncology, Inc. | √ | |
| Labcorp (for LUNAR study only) | √ | |
| Labcorp Drug Development, Inc. | √ | |
| LimFlow, Inc. | √ | |
| Linical Accelovance America, Inc. | √ | |
| Lisata Therapeutics, Inc. | √ | √ |
| Loxo Oncology | √ | |
| Lungpacer Medical, Inc. | √ | |
| Marker Therapeutics AG | √ | |
| MDD US Operations, LLC | √ | |
| Medpace, Inc. | √ | √ |
| Medtronic, Inc. | √ | |
| MEI Pharma, Inc. | √ | |
| Memo Therapeutics AG | √ | |
| Merck Sharp & Dohme, LLC | √ | √ |
| Miach Orthopaedics, Inc. | √ | |
| Microbion Corp. | √ | |
| Miltenyi Biomedicine GmbH | √ | |
| ModernaTX, Inc. | √ | √ |
| Molecular Templates, Inc. | √ | |
| Monteris Medical Corp. | √ | |
| Multiple Myeloma Research Consortium, LLC | √ | |
| MyoKardia, Inc. | √ | |
| Myovant Sciences GmbH | √ | |
| Natera, Inc. | √ | |
| National Institute of Mental Health (CREST study) | √ | |
| NCGS, Inc. | √ | |
| Neuren Pharmaceuticals, Inc. | √ | |
| Neurocrine Biosciences, Inc. | √ | |
| New England Research Institutes, Inc. (Pediatric Health Network) | √ | |
| NGM Biopharmaceuticals | √ | |
| Nobelpharma Co. | √ | |
| North American Science Associates, LLC | √ | |
| Novartis Pharmaceuticals Corp. | √ | |
| Novocure GmbH | √ | |
| Novotech Health Holdings | √ | |
| NRG Oncology | √ | √ |
| OncoBay Clinical, Inc. | √ | |
| OncoC4, Inc. | √ | √ |
| OncoNano | √ | |
| ONCOtherapeutics | √ | |
| Oregon Health & Science University | √ | |
| Osiris Therapeutics, Inc. | √ | |
| Oticon Medical, LLC | √ | |
| Pacific Edge, Ltd. | √ | |
| Palisade Bio, Inc. | √ | |
| Parexel- Covers Regeneron Studies Only | √ | |
| Parexel International, LLC | √ | |
| Pharm-Olam, LLC | √ | |
| Pharmaceutical Research Associates, Inc. | √ | |
| PharPoint Research, Inc. | √ | √ |
| Phasebio Pharmaceuticals, Inc. | √ | |
| Philips Image Guided Therapy Corporation | √ | |
| Pluristem, Ltd. | √ | |
| Plus Therapeutics, Inc. | √ | |
| PolyNovo North America, LLC | √ | |
| PPD Development, LP | √ | |
| PPD Investigator Services, LLC | √ | |
| PRA Health Sciences, on behalf of Eidos Therapeutics | √ | |
| Precision for Medicine | √ | |
| Premier Research International LLC, on behalf of Reneo | √ | |
| Profound Medical, Inc. | √ | |
| Proxima Clinical Research | √ | |
| PSI Pharma Support America, Inc. | √ | √ |
| Puma Biotechnology, Inc. | √ | √ |
| QED Therapeutics, Inc. | √ | |
| Quidel Corporation | √ | |
| PSI Pharma Support America, Inc. | √ | |
| Rafael Pharmaceuticals, Inc. | √ | |
| Reflexion Medical | √ | |
| Regeneron Pharmaceuticals, Inc. | √ | √ |
| Reflow Medical | √ | √ |
| Relay Therapeutics, Inc. | √ | |
| RenovoRx, Inc. | √ | |
| Rho, Inc. | √ | |
| Rivanna Medical, Inc. | √ | |
| RTOG Foundation, Inc. | √ | |
| Salubris Therapeutics, Inc. | √ | |
| Sandhill Therapeutics, Inc. | √ | |
| Sanofi US Services Inc. | √ | |
| Sarah Cannon Development Innovations, LLC | √ | |
| Seagen, Inc. | √ | |
| Seelos Therapeutics, Inc. | √ | |
| Semmes Murphey Foundation | √ | |
| Seno Medical Instruments, Inc. | √ | |
| Silverback Therapeutics, Inc. | √ | |
| Sollis Therapeutics | √ | |
| Sound Pharmaceuticals, Inc. | √ | |
| Steba Biotech, S.A. | √ | |
| Stemline Therapeutics | √ | |
| Stryker Corporation | √ | |
| Syneos (on behalf of Regeneron for study REGN5459) | √ | |
| Teleflex, Inc. | √ | √ |
| Tesaro, Inc (CRO - Pharmaceutical Research Associates) | √ | |
| TG Therapeutics, Inc. | √ | |
| The General Hospital Corporation d/b/a Massachusetts General Hospital | √ | |
| The Ohio State University | √ | |
| The University of Texas Health Science Center at San Antonio | √ | |
| Theradex Systems, Inc. | √ | |
| TissueTech, Inc. | √ | |
| Tolero Pharmaceuticals | √ | |
| TopAlliance Biosciences, Inc. | √ | |
| Translational Drug Development, LLC | √ | √ |
| TransMedics, Inc. | √ | |
| TransThera Sciences (Nanjing), Inc. | √ | |
| Trauma Insight, LLC | √ | |
| Treace Medical Concepts, Inc. | √ | |
| Trovagene, Inc. | √ | |
| Turning Point Therapeutics, Inc. | √ | |
| Tvardi Therapeutics, Inc. | √ | |
| United BioSource Corporation | √ | |
| United BioSource, LLC | √ | |
| University of Chicago | √ | |
| University of Iowa | √ | |
| University of Michigan | √ | |
| University of Pittsburgh | √ | |
| University of Texas M.D. Anderson Cancer Center | √ | |
| University of Utah | √ | |
| Vanderbilt University Medical Center | √ | |
| Varian Medical Systems, Inc. | √ | |
| Vaxiion Therapeutics, LLC | √ | |
| Venus Concept, Inc. | √ | |
| Verastem, Inc. | √ | √ |
| Veristat | √ | |
| Vertex Pharamaceuticals Incorporated | √ | |
| Vincerx Pharma, Inc. | √ | |
| W.L. Gore and Associates, Inc. | √ | |
| Westat, Inc. | √ | |
| Worldwide Clinical Trials, Inc. | √ | √ |
| Zentalis Inc. | √ | √ |
Please reference the Office of Clinical Research Personnel (OCRP) EpicCare Link (ECL) for Site Administrators Tip Sheet for more information.